Redmile Group LLC 13D and 13G filings for Kymera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:27 pm Purchase | 2022-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Redmile Group LLC | 2,673,837 4.900% | 86,107 (+3.33%) | Filing |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Redmile Group LLC | 2,587,730 5.000% | -132,759 (-4.88%) | Filing |
| 2021-02-16 4:10 pm Purchase | 2020-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Redmile Group LLC | 2,720,489 6.100% | 2,720,489 (New Position) | Filing |